Huzhou outlook Pharmaceutical Co., Ltd., located in the beautiful plain of Hangjia Hu, Zhejiang Province, China, as a " innovator of Chinese medicinal excipients " established in 1950, is a historic leading enterprise of medicinal excipients in China, while also being a few enterprises with full-length solid pharmaceutical excipients in China. Companies are mainly based on Producing Pharmaceutical Co materials and produce food additives. Now, the company has 25 varieties of pharmaceutical excipients, 9 varieties of crude drugs and 7 food additives, forming a comprehensive large-scale pharmaceutical manufacturing enterprise with three main series of products including pharmaceutical excipients, crude drugs and food additives. Huzhou outlook Pharmaceutical Co., Ltd., in 2015, became a wholly owned subsidiary of Tianjin HongJapanese Pharmaceutical Co., Ltd. (Stock Code: 300026), was awarded the title " excellent enterprise brand of pharmaceutical excipients in China's chemical and pharmaceutical industry " for five consecutive years, and has been awarded " high technology enterprise ", " Zhejiang Province integrity demonstration enterprise" Et al. Two production sites were set up under Huzhou outlook Pharmaceutical Co., Ltd. turbot and Huzhou, of which Huzhou, i.e., Huzhou chanwang Tianming Pharmaceutical Co., Ltd., is a wholly owned subsidiary of Huzhou outlook Pharmaceutical Co., Ltd. Outlook the pharmaceutical industry has successively passed the US FDA and EU cos certification, ISO, ISO, 14001 environmental protection certification. Now the company has international first class pharmaceutical inspection and testing equipment, and has several advanced pharmaceutical excipient production lines. In 2001, the pharmaceutical excipient R &D center looking forward to the pharmaceutical industry was recognized as" provincial high technology R &D center " by Zhejiang Provincial Department of science and technology. Relying on abundant technological strength, Huzhou outlook pharmaceutical industry has participated in the development and revision of several standards of pharmaceutical excipients. The products of R & D and production of the company have repeatedly been awarded a department, provincial award for scientific and technological progress, and some of these products are also listed as national key new products, the national Torch Program, the national innovation fund project.